I think there are two possibilities, much like I said last time
1. Mesoblast recieves a third CRL along with a request for a new trial.
2. Mesoblast receives a conditional approval for children. That is along the lines of the Canadian regulator, where they have a limited time eg two years to conduct a better controlled trial and if Mesoblast doesn't do it the approval is withdrawn.
I would expect that Mesoblast will get some revenues from that through Dr Kurtzberg it's but unlikely enough to cover expenses and costs, so they will continue to run at a loss. The time will expire without a result and approval will eventually be withdrawn. SI will squeal and write letters requesting new meetings and parade more anecdotal stories but this time the FDA will stand firm.
- Forums
- ASX - By Stock
- MSB
- MESO Nasdaq update
MESO Nasdaq update, page-5670
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
Add MSB (ASX) to my watchlist
|
|||||
Last
99.5¢ |
Change
-0.025(2.45%) |
Mkt cap ! $1.136B |
Open | High | Low | Value | Volume |
$1.02 | $1.04 | 99.5¢ | $4.379M | 4.328M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 163238 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 19700 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 163238 | 0.995 |
9 | 243839 | 0.990 |
9 | 168020 | 0.985 |
10 | 1078709 | 0.980 |
4 | 153741 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 19700 | 2 |
1.015 | 40041 | 3 |
1.020 | 69586 | 5 |
1.025 | 89541 | 3 |
1.030 | 118888 | 6 |
Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |